Gregory P. Licholai

Greg teaches Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Chief Innovation Officer at ICON plc, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He is co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained in neurosurgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on several healthcare company boards and medical advisory boards. Greg writes about innovation for Forbes.

Yale SOM Case Studies

• Population Health Management at Atrius
  Yale School of Management Case Study
  2016
   
• Nomad Health and the Disruption of Physician Staffing Services
  Yale School of Management Case Study
  2017
   
• Cobalt and the Rise of Digital Health
  Yale School of Management Case Study
  2018
   
• Everlywell and Creating Access to Lab Testing
  Yale School of Management Case Study
  2019
   
• Talkspace and digital health market dynamics
  Yale School of Management Case Study
  2019
   
• Medical Tourism, Neurosurgery and Singapore’s Largest Health System
  Yale School of Management Case Study
  2018
   
• CRISPR Therapeutics and Editing the Human Genome
  Yale School of Management Case Study
  2018
   
• The Health Data Insurgency
  Yale School of Management Case Study
  2020